She replaces Thierry Damerval, who has been appointed Chairman and CEO of the French National Research Agency (ANR).
Since July 2016, Claire Giry had been in charge of the “Centers of Excellence” program run by the Commissariat général à l’investissement (CGI – General Investment Commission).
She was previously Deputy Director for fundamental research at the CEA and Director of the Fontenay-aux-Roses research center primarily dedicated to life sciences. She had a number of roles relating to communication, European affairs and partnerships within the organization.
She led Inserm’s National and Foreign Affairs Department (national, European and international partnerships) between 2012 and 2014, and had previously set up the Ministry of Higher Education and Research’s Strategic and regional coordination service, shared by the DGESIP (Department for higher education and workplace integration) and the DGRI (Department for research and integration), responsible, in particular, for Investments for the Future and regions.
Between 2007 and 2009 Claire Giry was a technical advisor to the Prime Minister for higher education and research.
Born in 1970, she is a graduate of the ENS school in Lyon and holds a doctorate in molecular and cellular biology from Claude Bernard University in Lyon.
She was named “Chevalier de la Légion d’honneur” and “Chevalier dans l’Ordre national du mérite” (French National Order of Merit).
To become the most advanced and competitive genomics research and healthcare system in the world: such was the ambition declared by Inserm, and its partners Aviesan and Genomics England Ltd, during the UK-France Summit on January 18, 2018. An agreement was signed ...